S. Tennenberg et al., A PROSPECTIVE RANDOMIZED TRIAL OF AN ANTIBIOTIC-COATED AND ANTISEPTIC-COATED CENTRAL VENOUS CATHETER IN THE PREVENTION OF CATHETER-RELATED INFECTIONS, Archives of surgery, 132(12), 1997, pp. 1348-1351
Objective: To test the efficacy of the ARROWgard (Arrow International
Inc, Reading, Pa) central venous catheter (CVC) coated with silver sul
fadiazine and chlorhexidine (A-CVC) in the prevention of CVC-related i
nfections. Design: Prospective, randomized trial. Setting: A tertiary
care medical center. Patients and Intervention: Two hundred eighty-two
patients who required CVC placement were evaluated in this study. Pat
ients were prospectively randomized to receive either a standard CVC (
S-CVC) or the A-CVC. Only fresh-stick double-and triple-lumen catheter
s were studied. Main Outcome Measures: Patients were evaluated for cat
heter site inflammation, catheter site colonization, local catheter-re
lated infection, and catheter-related septicemia. Results: The 2 group
s were matched for age, percentage in the intensive care unit, percent
age receiving total parenteral nutrition, percentage with triple-lumen
catheters, and duration of catheterization. Rates of catheter site in
flammation in the 2 groups were similar (12% vs 10%, S-CVC group and A
-CVC group, respectively). The A-CVC was associated with a significant
ly decreased catheter site colonization rate (49% vs 28%; 43% reductio
n; P<.001) and local catheter-related infection rate (22.4% vs 5.8%; 7
4% reduction; P<.001). Rates of catheter-related septicemia were reduc
ed by 41% in the A-CVC group (6.4% vs 3.8%, S-CVC group and A-CVC grou
p, respectively), but this was not statistically significant, Conclusi
ons: Despite a marked decrease in catheter site colonization and cathe
ter-related infection rates, the A-CVC did not significantly reduce th
e incidence of catheter-related septicemia. This may be due to a great
er pathogenic dependence on catheter hub contamination rather than cat
heter site colonization or local catheter-related infection, or the re
latively short (5.2 days) duration of catheterization in this study.